嗅神经母细胞瘤(嗅神经上皮瘤):6例采用内镜手术与放射外科新联合治疗的报告
Olfactory neuroblastoma (esthesioneuroblastoma): report of six cases treated by a novel combination of endoscopic surgery and radiosurgery.
作者信息
Unger F, Walch C, Stammberger H, Papaefthymiou G, Haselsberger K, Pendl G
机构信息
Department of Neurosurgery, Karl-Franzens University, Graz, Austria.
出版信息
Minim Invasive Neurosurg. 2001 Jun;44(2):79-84. doi: 10.1055/s-2001-16000.
Microsurgical techniques have considerably improved the results of surgical treatment for esthesioneuroblastoma (olfactory neuroblastoma). Nevertheless, these rare tumours of the frontal skull base are still associated with high rates of tumour recurrence and mortality, thus remaining a challenge even for experienced surgeons. A novel therapeutic approach that combines endoscopic sinus surgery and radiosurgery (gamma knife) is presented here. Six patients (3 males, 3 females) aged between 27 and 75 years (median 38 years) were treated between August 1993 and July 1999. Following paranasal and nasal endoscopic sinus surgery, marginal irradiation doses ranging from 16 to 34 Gy were applied radiosurgically involving up to 7 isocentres. At present, the median follow-up period is 57 months (range: 9 - 79 months). Without mortality, tumour control was achieved in all patients. One patient, who had to undergo additional craniotomy because of extensive neoplastic infiltration, developed postoperative liquorrhea. In another case the clinical course was complicated by a bilateral frontal sinusitis. All patients complained of nasal discharge and crusts. However, a preoperative Karnovsky Index ranging from 80 to 100 % remained stable in four patients whereas an improvement was observed in two patients. Based on the favourable results observed so far, the combination of endoscopic sinus surgery and radiosurgery can be considered as promising new option for the treatment of esthesioneuroblastoma that merits further investigation.
显微外科技术已显著改善了嗅神经母细胞瘤手术治疗的效果。然而,这些发生于额颅底的罕见肿瘤仍伴有较高的肿瘤复发率和死亡率,即便对于经验丰富的外科医生而言仍是一项挑战。本文介绍了一种将鼻内镜鼻窦手术与放射外科(伽玛刀)相结合的新型治疗方法。1993年8月至1999年7月期间,对6例年龄在27至75岁(中位年龄38岁)的患者(3例男性,3例女性)进行了治疗。在鼻旁和鼻内镜鼻窦手术后,通过放射外科应用16至34 Gy的边缘照射剂量,涉及多达7个等中心。目前,中位随访期为57个月(范围:9至79个月)。无一例死亡,所有患者均实现了肿瘤控制。1例因肿瘤广泛浸润而不得不接受额外开颅手术的患者出现了术后脑脊液漏。在另一例中,临床过程因双侧额窦炎而复杂化。所有患者均有鼻分泌物和结痂。然而,4例患者术前卡氏评分在80%至100%之间保持稳定,而2例患者有所改善。基于目前观察到的良好结果,鼻内镜鼻窦手术与放射外科的联合可被视为治疗嗅神经母细胞瘤的一种有前景的新选择,值得进一步研究。